According to BlockBeats news, on August 8, Core Scientific's largest shareholder, Two Seas Capital, announced that it would vote against the all-stock sale of the company to CoreWeave, stating that the transaction's valuation is too low and has serious structural flaws.
In July this year, CoreWeave announced the acquisition of digital infrastructure company Core Scientific through an all-stock transaction. The value per share for this transaction is $20.40. The agreed exchange ratio implies that the company's valuation is approximately $9 billion.